GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Aidea Pharmaceutical Co Ltd (SHSE:688488) » Definitions » Growth Rank

Jiangsu Aidea Pharmaceutical Co (SHSE:688488) Growth Rank : 0 (As of Apr. 24, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Jiangsu Aidea Pharmaceutical Co Growth Rank?

Jiangsu Aidea Pharmaceutical Co has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


Jiangsu Aidea Pharmaceutical Co Growth Rank Related Terms

Thank you for viewing the detailed overview of Jiangsu Aidea Pharmaceutical Co's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Aidea Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 2 Liuzhuang Road, Hanjiang District, Jiangsu Province, Yangzhou, CHN, 225008
Jiangsu Aidea Pharmaceutical Co Ltd produces and sells human-derived protein products, and also develops some generic drug businesses and distributes Abbott's HIV diagnostic equipment and reagents. The company focuses on development of new chemical entities of anti-tumor, anti-virus and cardiovascular areas, among which two NCE drugs for the treatment of Cancer and AIDS have been approved.
Executives
Wang Jun Directors, senior managers
Fu He Liang Director, core technical staff
Zhang Jie Directors, senior managers
Yuan Yu Core technical personnel
Su Gu Fang Core technical personnel
Zhang Ji Bing Core technical personnel
Wang Guang Rong Directors, senior managers
Yu Ke Directors, senior managers

Jiangsu Aidea Pharmaceutical Co Headlines

No Headlines